Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian L Hvas

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Immunology Letters|June 13, 2017
Immune responses and parasitological observations induced during probiotic treatment with medicinal Trichuris suis ova in a healthy volunteerAndrew R Williams, Anders Dige, Tue Kruse Rasmussen, et al.
Inflammatory Bowel Diseases|May 13, 2017
Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel DiseaseMette Julsgaard, Christian L Hvas, Richard B Gearry, et al.
Diabetologia|September 18, 2025
Repeated faecal microbiota transplantation for individuals with type 1 diabetes and gastroenteropathyKatrine L Høyer, Ditte S Kornum, Simon M D Baunwall, et al.
Journal of Clinical Gastroenterology|April 18, 2020
The Citrullinated and MMP-degraded Vimentin Biomarker (VICM) Predicts Early Response to Anti-TNFα Treatment in Crohn's DiseaseJoachim H Mortensen, Wouter T van Haaften, Morten A Karsdal, et al.
Therapeutic Advances in Gastroenterology|April 23, 2019
Cost savings following faecal microbiota transplantation for recurrent <i>Clostridium difficile</i> infectionEmilie Dehlholm-Lambertsen, Bianca K Hall, Simon M D Jørgensen, et al.
Clinical and Translational Gastroenterology|October 23, 2020
Serological Biomarkers of Tissue Turnover Identify Responders to Anti-TNF Therapy in Crohn's Disease: A Pilot StudyWouter T van Haaften, Joachim H Mortensen, Anders K Dige, et al.
Alimentary Pharmacology & Therapeutics|July 24, 2023
Donor, patient age and exposure to antibiotics are associated with the outcome of faecal microbiota transplantation for recurrent Clostridioides difficile infection: A prospective cohort studySimon M D Baunwall, Mette M Hansen, Sara E Andreasen, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 18, 2026
Spermidine and spermine in elderly patients with coronary artery disease: a cross-sectional study of dietary intake and plasma and skeletal muscle concentrationsChristian Thorup, Thomas H Jensen, Chris N A Jeppesen, et al.
Alimentary Pharmacology & Therapeutics|September 2, 2021
Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort studyMette Julsgaard, Daniel C Baumgart, Simon M D Baunwall, et al.
Gastroenterology|April 12, 2016
Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on InfectionMette Julsgaard, Lisbet A Christensen, Peter R Gibson, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Immunology Letters|June 13, 2017
Immune responses and parasitological observations induced during probiotic treatment with medicinal Trichuris suis ova in a healthy volunteerAndrew R Williams, Anders Dige, Tue Kruse Rasmussen, et al.
Inflammatory Bowel Diseases|May 13, 2017
Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel DiseaseMette Julsgaard, Christian L Hvas, Richard B Gearry, et al.
Diabetologia|September 18, 2025
Repeated faecal microbiota transplantation for individuals with type 1 diabetes and gastroenteropathyKatrine L Høyer, Ditte S Kornum, Simon M D Baunwall, et al.
Journal of Clinical Gastroenterology|April 18, 2020
The Citrullinated and MMP-degraded Vimentin Biomarker (VICM) Predicts Early Response to Anti-TNFα Treatment in Crohn's DiseaseJoachim H Mortensen, Wouter T van Haaften, Morten A Karsdal, et al.
Therapeutic Advances in Gastroenterology|April 23, 2019
Cost savings following faecal microbiota transplantation for recurrent <i>Clostridium difficile</i> infectionEmilie Dehlholm-Lambertsen, Bianca K Hall, Simon M D Jørgensen, et al.
Clinical and Translational Gastroenterology|October 23, 2020
Serological Biomarkers of Tissue Turnover Identify Responders to Anti-TNF Therapy in Crohn's Disease: A Pilot StudyWouter T van Haaften, Joachim H Mortensen, Anders K Dige, et al.
Alimentary Pharmacology & Therapeutics|July 24, 2023
Donor, patient age and exposure to antibiotics are associated with the outcome of faecal microbiota transplantation for recurrent Clostridioides difficile infection: A prospective cohort studySimon M D Baunwall, Mette M Hansen, Sara E Andreasen, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 18, 2026
Spermidine and spermine in elderly patients with coronary artery disease: a cross-sectional study of dietary intake and plasma and skeletal muscle concentrationsChristian Thorup, Thomas H Jensen, Chris N A Jeppesen, et al.
Alimentary Pharmacology & Therapeutics|September 2, 2021
Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort studyMette Julsgaard, Daniel C Baumgart, Simon M D Baunwall, et al.
Gastroenterology|April 12, 2016
Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on InfectionMette Julsgaard, Lisbet A Christensen, Peter R Gibson, et al.
Pageof 4